Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Integrilin eptifibatide: Phase IV data

In the open-label, U.S. Phase IV CLEAR PLATELETS 2 study in 200

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE